Advocates Experiment With Novel Legal Approaches On Mifepristone

Following the latest development in FDA’s ongoing review of mifepristone -- a letter from HHS leadership suggesting the agency is preparing to reinstate in-person requirements to obtain the abortion drug -- a California lawmaker aiming to allow the state to manufacture its own mifepristone says her legislation should go forward even though it’s unclear whether courts would rule it is preempted by federal law.